Arcellx, Inc. (ACLX)

NASDAQ: ACLX · Real-Time Price · USD

69.56

+1.11 (1.62%)

At close: Dec 5, 2025, 4:00 PM EST

71.90

+2.34 (3.36%)

After-hours: Dec 5, 2025, 6:13 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cell Therapies	107.94M	Log In
Cell Therapies Growth	-2.16%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	107.94M	Log In
United States Growth	-2.16%	Log In